Cited by 692Multiple Sclerosis Research StudiesNeuroinflammation and Neurodegeneration MechanismsPeripheral Neuropathies and Disorders

The DOI matches its Crossref record; 60 of the 60 references it cites were found in a registry or an index.

An updated histological classification system for multiple sclerosis lesions

Kuhlmann, Tanja, Ludwin, Samuel, Prat, Alexandre, Antel, Jack, Brück, Wolfgang, Lassmann, Hans·2017·Acta Neuropathologica

DOI 10.1007/s00401-016-1653-y

Open this paper in CoChat — free account

Abstract

Multiple sclerosis is a complex and heterogeneous, most likely autoimmune, demyelinating disease of the central nervous system (CNS). Although a number of histological classification systems for CNS lesions have been used by different groups in recent years, no uniform classification exists. In this paper, we propose a simple and unifying classification of MS lesions incorporating many elements of earlier histological systems that aims to provide guidelines for neuropathologists and researchers studying MS lesions to allow for better comparison of different studies performed with MS tissue, and to aid in understanding the pathogenesis of the disease. Based on the presence/absence and distribution of macrophages/microglia (inflammatory activity) and the presence/absence of ongoing demyelination (demyelinating activity), we suggest differentiating between active, mixed active/inactive, and inactive lesions with or without ongoing demyelination. Active lesions are characterized by macrophages/microglia throughout the lesion area, whereas mixed active/inactive lesions have a hypocellular lesion center with macrophages/microglia limited to the lesion border. Inactive lesions are almost completely lacking macrophages/microglia. Active and mixed active/inactive lesions can be further subdivided into lesions with ongoing myelin destruction (demyelinating lesions) and lesions in which the destruction of myelin has ceased, but macrophages are still present (post-demyelinating lesions). This distinction is based on the presence or absence of myelin degradation products within the cytoplasm of macrophages/microglia. For this classification of MS lesions, identification of myelin with histological stains [such as luxol fast blue-PAS] or by immunohistochemistry using antibodies against myelin basic-protein (MBP) or proteolipid-protein (PLP), as well as, detection of macrophages/microglia by, e.g., anti-CD68 is sufficient. Active and demyelinating lesions may be further subdivided into the early and late demyelinating lesions. The former is defined by the presence in macrophages of major and small molecular weight myelin proteins, such as cyclic nucleotide diphosphoesterase (CNP), myelin oligodendrocyte glycoprotein (MOG), or myelin-associated protein (MAG), whereas macrophages in the latter demonstrate merely the presence of the major myelin proteins MBP or PLP. We discuss the histological features and staining techniques required to classify MS lesions, and, in addition, describe the histological hallmarks of cortical pathology and diffuse white matter changes, as well as of remyelination.

Integrity signals

Registry

Crossref · 10.1007/s00401-016-1653-y

Cites

60 of 60 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Axonal transection in the lesions of multiple sclerosis
Trapp, B. D., Peterson, J., Ransohoff, R. M., Rudick, R., Mörk, S., & Bö, L. (1998) · New England Journal of Medicine · doi:10.1056/nejm199801293380502 · Cited by 4,029
Identification of a unique TGF-β–dependent molecular and functional signature in microglia
Butovsky, O., Jedrychowski, M. P., Moore, C. S., Cialic, R., Lanser, A. J., Gabriely, G., Koeglsperger, T., Dake, B., Wu, P. M., Doykan, C. E., et al. (2014) · Nature Neuroscience · doi:10.1038/nn.3599 · Cited by 2,543
Self-citation
Immunopathology of multiple sclerosis
Dendrou, C. A., Fugger, L., & Friese, M. A. (2015) · Nature Reviews Immunology · doi:10.1038/nri3871 · Cited by 2,215
Cortical demyelination and diffuse white matter injury in multiple sclerosis
Kutzelnigg, A., Lucchinetti, C. F., Stadelmann, C., Brück, W., Rauschka, H., Bergmann, M., Schmidbauer, M., Parisi, J. E., & Lassmann, H. (2005) · Brain · doi:10.1093/brain/awh641 · Cited by 1,836
Self-citation
The relation between inflammation and neurodegeneration in multiple sclerosis brains
Frischer, J. M., Bramow, S., Dal-Bianco, A., Lucchinetti, C. F., Rauschka, H., Schmidbauer, M., Laursen, H., Sorensen, P. S., & Lassmann, H. (2009) · Brain · doi:10.1093/brain/awp070 · Cited by 1,450
Self-citation
Transected neurites, apoptotic neurons, and reduced inflammation in cortical multiple sclerosis lesions
Peterson, J. W., Bö, L., Mörk, S., Chang, A., & Trapp, B. D. (2001) · Annals of Neurology · doi:10.1002/ana.1123 · Cited by 1,403 · cited 1×
“Lucchinetti and colleagues have shown extensive cortical inflammatory T-cell infiltrates in early MS lesions (9), however, especially in patients in the progressive disease phase, inflammatory activity in cortical lesions (especially T cells) is, in general, lower than in the adjacent white matter lesions [6, 10, 45].”
Background
Pathological mechanisms in progressive multiple sclerosis
Mahad, D., Trapp, B. D., & Lassmann, H. (2015) · The Lancet Neurology · doi:10.1016/s1474-4422(14)70256-x · Cited by 1,198
Self-citation
Relapsing and remitting multiple sclerosis: Pathology of the newly forming lesion
Barnett, M. H., & Prineas, J. W. (2004) · Annals of Neurology · doi:10.1002/ana.20016 · Cited by 1,184
The Immunopathology of Multiple Sclerosis: An Overview
Lassmann, H., Brück, W., & Lucchinetti, C. F. (2007) · Brain Pathology · doi:10.1111/j.1750-3639.2007.00064.x · Cited by 1,182
Self-citation
Differentiation block of oligodendroglial progenitor cells as a cause for remyelination failure in chronic multiple sclerosis
Kuhlmann, T., Miron, V., Cuo, Q., Wegner, C., Antel, J., & Bruck, W. (2008) · Brain · doi:10.1093/brain/awn096 · Cited by 864
Self-citation

Show all 59 references

Research works printed but not linked: 1

Prineas JW (1985) The neuropathology of multiple sclerosis. In: Koetsier JC (ed) Demyelinating Diseases. Elsevier Science Publishers, Amsterdam, pp 213–257

Sorted by citations

Items 301–400 of 688

Proteomic signatures of neuroinflammation in Alzheimer’s disease, multiple sclerosis and ischemic stroke
Thygesen, C., Larsen, M. R., & Finsen, B. R. (2019) · Expert Review of Proteomics · doi:10.1080/14789450.2019.1633919 · Cited by 18
Fundamental mechanistic insights from rare but paradigmatic neuroimmunological diseases
Wiendl, H., Groß, C. C., Bauer, J., Merkler, D., Prat, A., & Liblau, R. (2021) · Nature Reviews Neurology · doi:10.1038/s41582-021-00496-7 · Cited by 20
Self-citation
The Neuroimmunology of Multiple Sclerosis: Fictions and Facts
Pachner, A. R. (2022) · Frontiers in Neurology · doi:10.3389/fneur.2021.796378 · Cited by 19
Distinct transcriptional changes distinguish efficient and poor remyelination in multiple sclerosis
Chen, J. Q. A., McNamara, N. B., Engelenburg, H. J., Jongejan, A., Wever, D. D., Hopman, K., van Rixel, E., Nijhuis, P. J. H., de Winter, F., Moerland, P. D., et al. (2025) · Brain · doi:10.1093/brain/awae414 · Cited by 17
Innate immune cells and myelin profile in multiple sclerosis: a multi-tracer PET/MR study
Pitombeira, M. S., Koole, M. J. B., Campanholo, K. R., de Souza, A. B. P., Duran, F., Solla, D. J. F., Mendes, M. F., Apóstolos‐Pereira, S. L., Rimkus, C. D. M., Busatto, G. F., et al. (2022) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-022-05899-2 · Cited by 20
The Distributional Characteristics of Multiple Sclerosis Lesions on Quantitative Susceptibility Mapping and Their Correlation With Clinical Severity
Guo, Z., Long, L., Qiu, W., Lü, T., Zhang, L., Shu, Y., Zhang, K., Fang, L., & Chen, S. (2021) · Frontiers in Neurology · doi:10.3389/fneur.2021.647519 · Cited by 17
Biomolecular Evaluation of Piceatannol’s Effects in Counteracting the Senescence of Mesenchymal Stromal Cells: A New Candidate for Senotherapeutics?
Alessio, N., Squillaro, T., Lettiero, I., Galano, G., Rosa, R. D., Peluso, G., Galderisi, U., & Bernardo, G. D. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222111619 · Cited by 17
Activation of the Protective Arm of the Renin Angiotensin System in Demyelinating Disease
Stone, R., Liu, S., Levy, A. M., Kashani, N., Louie, S. G., Rodgers, K. E., Kelland, E. E., & Lund, B. T. (2019) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-019-09894-7 · Cited by 17
BCAS1-positive oligodendrocytes enable efficient cortical remyelination in multiple sclerosis
Bergner, C. G., van der Meer, F., Franz, J., Vakrakou, A., Würfel, T., Nessler, S., Schäfer, L., Nau-Gietz, C., Winkler, A., Lagumersindez-Denis, N., et al. (2025) · Brain · doi:10.1093/brain/awae293 · Cited by 16
“To test whether a similar early response to demyelination can be observed in human cortical demyelination, we assessed grey matter lesions obtained from brain biopsies of patients with MS early in the disease course 32,40 for the presence of BCAS1+ oligodendrocytes.”
Quantitative 7-Tesla Imaging of Cortical Myelin Changes in Early Multiple Sclerosis
Barletta, V. T., Herranz, E., Treaba, C. A., Mehndiratta, A., Ouellette, R., Mangeat, G., Granberg, T., Sloane, J. A., Klawiter, E. C., Cohen‐Adad, J., et al. (2021) · Frontiers in Neurology · doi:10.3389/fneur.2021.714820 · Cited by 16
Modulation of the Microglial Nogo-A/NgR Signaling Pathway as a Therapeutic Target for Multiple Sclerosis
Nheu, D., Ellen, O., Ye, S., Öztürk, E., Pagnin, M., Kertadjaja, S., Theotokis, P., Grigoriadis, N., McLean, C., & Petratos, S. (2022) · Cells · doi:10.3390/cells11233768 · Cited by 16
Alcohol-induced damage to the fimbria/fornix reduces hippocampal-prefrontal cortex connection during early abstinence
Pérez-Cervera, L., Santis, S. D., Marcos, E., Ghorbanzad-Ghaziany, Z., Carpena, A. T., Selim, M. K., Pérez‐Ramírez, Ú., Pfarr, S., Bach, P., Halli, P., et al. (2023) · Acta Neuropathologica Communications · doi:10.1186/s40478-023-01597-8 · Cited by 17
ALCAM on human oligodendrocytes mediates CD4 T cell adhesion
Jamann, H., Desu, H. L., Cui, Q., Halaweh, A., Tastet, O., Klément, W., Zandee, S., Pernin, F., Mamane, V. H., Ouédraogo, O., et al. (2023) · Brain · doi:10.1093/brain/awad286 · Cited by 16
Self-citation
Microglia activation in periplaque white matter in multiple sclerosis depends on age and lesion type, but does not correlate with oligodendroglial loss
Kessler, W., Thomas, C., & Kuhlmann, T. (2023) · Acta Neuropathologica · doi:10.1007/s00401-023-02645-2 · Cited by 17
Self-citation
Combination of Hydroxychloroquine and Indapamide Attenuates Neurodegeneration in Models Relevant to Multiple Sclerosis
Brown, D., Moezzi, D., Dong, Y., Koch, M. W., & Yong, V. W. (2021) · Neurotherapeutics · doi:10.1007/s13311-020-01002-5 · Cited by 16
Interleukin-1 receptor antagonist: An exploratory plasma biomarker that correlates with disability and provides pathophysiological insights in relapsing-remitting multiple sclerosis
Blandford, S. N., Galloway, D. A., Williams, J. B., Arsenault, S. T., Brown, J. E., MacLean, G., Moore, G. R. W., Barron, J., Ploughman, M., Clift, F., et al. (2021) · Multiple Sclerosis and Related Disorders · doi:10.1016/j.msard.2021.103006 · Cited by 16
BASHY Dye Platform Enables the Fluorescence Bioimaging of Myelin Debris Phagocytosis by Microglia during Demyelination
Pinto, M. V., Santos, F. M. F., Barros, C., Ribeiro, A. R., Pischel, U., Góis, P. M. P., & Fernandes, A. M. A. (2021) · Cells · doi:10.3390/cells10113163 · Cited by 17
Myelin Quantification in White Matter Pathology of Progressive Multiple Sclerosis Post-Mortem Brain Samples: A New Approach for Quantifying Remyelination
Huitema, M. J. D., Strijbis, E. M. M., Luchicchi, A., Bol, J. G. J. M., Plemel, J. R., Geurts, J. J. G., & Schenk, G. J. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222312634 · Cited by 16
Distribution Pattern of the Monoamine Oxidase B Ligand, 18F-THK5351, in the Healthy Brain
Ishibashi, K., Miura, Y., Tago, T., Toyohara, J., Higashihara, M., Iwata, A., & Ishii, K. (2022) · Clinical Nuclear Medicine · doi:10.1097/rlu.0000000000004272 · Cited by 16
Microstructural alterations in different types of lesions and their perilesional white matter in relapsing-remitting multiple sclerosis based on diffusion kurtosis imaging
Shi, Z., Pan, Y., Yan, Z., Ding, S., Hu, H., Wei, Y., Luo, D., Xu, Y., Zhu, Q., & Li, Y. (2023) · Multiple Sclerosis and Related Disorders · doi:10.1016/j.msard.2023.104572 · Cited by 15
Secretomics reveals gelatinase substrates at the blood-brain barrier that are implicated in astroglial barrier function
Burmeister, M., Frauenstein, A., Kahms, M., Arends, L., Gerwien, H., Deshpande, T., Kuhlmann, T., Groß, C. C., Naik, V. N., Wiendl, H., et al. (2023) · Science Advances · doi:10.1126/sciadv.adg0686 · Cited by 16
Self-citation
Expression profiling of cerebrospinal fluid identifies dysregulated antiviral mechanisms in multiple sclerosis
Ban, M., Bredikhin, D., Huang, Y., Bonder, M. J., Katarzyna, K., Oliver, A. J., Wilson, N. K., Coupland, P. G., Hadfield, J., Göttgens, B., et al. (2023) · Brain · doi:10.1093/brain/awad404 · Cited by 15
High Levels of Perivascular Inflammation and Active Demyelinating Lesions at Time of Death Associated with Rapidly Progressive Multiple Sclerosis Disease Course: A Retrospective Postmortem Cohort Study
Nicholas, R. S., Magliozzi, R., Marastoni, D., Howell, O. W., Roncaroli, F., Muraro, P. A., Reynolds, R., & Friede, T. (2023) · Annals of Neurology · doi:10.1002/ana.26870 · Cited by 15
Secondary progressive multiple sclerosis — from neuropathology to definition and effective treatment
Adamczyk-Sowa, M. H., Adamczyk, B., Kułakowska, A., Rejdak, K., & Nowacki, P. (2020) · Neurologia i Neurochirurgia Polska · doi:10.5603/pjnns.a2020.0082 · Cited by 15
CLMP Promotes Leukocyte Migration Across Brain Barriers in Multiple Sclerosis
Fournier, A. P., Zandee, S., Charabati, M., Peelen, E., Tastet, O., Alvarez, J. I., Kébir, H., Bourbonnière, L., Larouche, S., Lahav, B., et al. (2022) · Neurology Neuroimmunology & Neuroinflammation · doi:10.1212/nxi.0000000000200022 · Cited by 15
Self-citation
Automated separation of diffusely abnormal white matter from focal white matter lesions on MRI in multiple sclerosis
Maranzano, J., Dadar, M., Zhernovaia, M., Arnold, D. L., Collins, D. L., & Narayanan, S. (2020) · NeuroImage · doi:10.1016/j.neuroimage.2020.116690 · Cited by 16
Estimation of Multiple Sclerosis lesion age on magnetic resonance imaging
Sweeney, E. M., Nguyen, T. D., Kuceyeski, A. F., Ryan, S., Zhang, S., Zexter, L., Wang, Y., & Gauthier, S. A. (2020) · NeuroImage · doi:10.1016/j.neuroimage.2020.117451 · Cited by 16
Modeling compartmentalized chronic immune-mediated demyelinating CNS disease in the Biozzi ABH mouse
Nishri, Y., Fainstein, N., Goldfarb, S., Hampton, D., Macrini, C., Meinl, E., Chandran, S., & Ben-Hur, T. (2021) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2021.577582 · Cited by 14
Chimeric antigen receptor cell therapy: A revolutionary approach transforming cancer treatment to autoimmune disease therapy
Wen, R., Li, B., Wu, F., Mao, J., Azad, T., Wang, Y., Zhu, J., Zhou, X. Y., Xie, H., Qiu, X., et al. (2025) · Autoimmunity Reviews · doi:10.1016/j.autrev.2025.103859 · Cited by 14
Longitudinal accumulation of glial activation measured by TSPO-PET predicts later brain atrophy in multiple sclerosis
Nylund, M., Lehto, J., Matilainen, M., Rajander, J., Wahlroos, S., Sucksdorff, M., Kuhlmann, T., & Airas, L. (2025) · Journal of Neuroinflammation · doi:10.1186/s12974-025-03519-y · Cited by 18
Self-citation
Exploring in vivo lesion myelination dynamics: Longitudinal Myelin Water Imaging in early Multiple Sclerosis
Kitzler, H. H., Wahl, H., Kuntke, P., Deoni, S., Ziemssen, T., Linn, J., & Köhler, C. (2022) · NeuroImage Clinical · doi:10.1016/j.nicl.2022.103192 · Cited by 14
Defining the pig microglial transcriptome reveals its core signature, regional heterogeneity, and similarity with human and rodent microglia
Shih, B. B.-J., Brown, S. M., Barrington, J., Lefèvre, L., Mabbott, N. A., Priller, J., Thompson, G., Lawrence, A. B., & McColl, B. W. (2022) · Glia · doi:10.1002/glia.24274 · Cited by 14
PET imaging of TREM1 identifies CNS-infiltrating myeloid cells in a mouse model of multiple sclerosis
Chaney, A. M., Cropper, H. C., Jain, P., Wilson, E. N., Simonetta, F., Johnson, E. M., Alam, I. S., Patterson, I. T. J., Swarovski, M. S., Stevens, M. Y., et al. (2023) · Science Translational Medicine · doi:10.1126/scitranslmed.abm6267 · Cited by 14
Basic Science of Neuroinflammation and Involvement of the Inflammatory Response in Disorders of the Nervous System
Parsi, S., Zhu, C., Motlagh, N. J., Kim, D., Kuellenberg, E. G., Kim, H.-H., Gillani, R. L., & Chen, J. W. (2024) · Magnetic Resonance Imaging Clinics of North America · doi:10.1016/j.mric.2024.01.003 · Cited by 15
Percutaneous transluminal angioplasty for treatment of chronic cerebrospinal venous insufficiency (CCSVI) in people with multiple sclerosis
Jagannath, V. A., Pucci, E., Asokan, G. V., & Robak, E. W. (2019) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd009903.pub3 · Cited by 14
Impact of Lesion Location on Longitudinal Myelin Water Fraction Change in Chronic Multiple Sclerosis Lesions
Pandya, S., Kaunzner, U. W., Rúa, S. M. H., Nealon, N., Perumal, J. S., Vartanian, T. K., Nguyen, D. T., & Gauthier, S. A. (2020) · Journal of Neuroimaging · doi:10.1111/jon.12716 · Cited by 14
Remyelination therapies for multiple sclerosis: optimizing translation from animal models into clinical trials
Sutiwisesak, R., Burns, T. C., Rodriguez, M., & Warrington, A. E. (2021) · Expert Opinion on Investigational Drugs · doi:10.1080/13543784.2021.1942840 · Cited by 14
Ameliorative effects of acetyl-L-carnitine on corpus callosum and functional recovery in demyelinated mouse model
Gharighnia, S., Omidi, A., Kashani, I. R., Sepand, M. R., & Beiranvand, S. P. (2022) · International Journal of Neuroscience · doi:10.1080/00207454.2022.2107515 · Cited by 15
Pathologic and MRI analysis in acute atypical inflammatory demyelinating lesions
Ayrignac, X., Rigau, V., Lhermitte, B., Vincent, T., de Champfleur, N. M., Dalliere, C. C., Charif, M., Collongues, N., Seze, J. D., Hebbadj, S., et al. (2019) · Journal of Neurology · doi:10.1007/s00415-019-09328-7 · Cited by 14
CNS macrophage contributions to myelin health
Hoffmann, A., & Miron, V. E. (2024) · Immunological Reviews · doi:10.1111/imr.13416 · Cited by 13
Transforming Growth Factor β1 Protects Against Ischemic Demyelination via Regulating Microglial Lipid Metabolism Pathway
Xie, Y., Wang, X., Liu, S., He, Z., Zhang, H., Yu, Z., Xie, M., & Wang, W. (2025) · Stroke · doi:10.1161/strokeaha.124.048206 · Cited by 13
Network Analysis in Multiple Sclerosis and Related Disorders
Pontillo, G., Barrantes-Cepas, M., Broeders, T. A. A., Koubiyr, I., & Schoonheim, M. M. (2024) · Neuroimaging Clinics of North America · doi:10.1016/j.nic.2024.03.008 · Cited by 13
From BBB to PPP : Bioenergetic requirements and challenges for oligodendrocytes in health and disease
Fernandes, M. G. F., Pernin, F., Antel, J. P., & Kennedy, T. E. (2024) · Journal of Neurochemistry · doi:10.1111/jnc.16219 · Cited by 13
Self-citation
Global perspectives on the contribution of B cells to multiple sclerosis: an in-depth examination and evaluation
Jiang, X., Zhang, H., Liu, Y., Sun, B., & Mu, G. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1442694 · Cited by 13
Multiple Sclerosis: Glial Cell Diversity in Time and Space
Kooistra, S. M., & Schirmer, L. (2024) · Glia · doi:10.1002/glia.24655 · Cited by 14
Comparison of two different methods of image analysis for the assessment of microglial activation in patients with multiple sclerosis using (R)-[N-methyl-carbon-11]PK11195
Kang, Y., Schlyer, D. J., Kaunzner, U. W., Kuceyeski, A. F., Kothari, P. J., & Gauthier, S. A. (2018) · PLoS ONE · doi:10.1371/journal.pone.0201289 · Cited by 13
Meningeal B Cell Clusters Correlate with Submeningeal Pathology in a Natural Model of Multiple Sclerosis
Church, M. E., Ceja, G., McGeehan, M., Miller, M. C., Farias, P., Sánchez, M. D., Swain, G. P., Assenmacher, C., Stopa, E. G., Vite, C. H., et al. (2021) · The Journal of Immunology · doi:10.4049/jimmunol.2000514 · Cited by 13
Tissue donations for multiple sclerosis research: current state and suggestions for improvement
Vanderdonckt, P., Aloisi, F., Comı, G., de Bruyn, A., Hartung, H., Huitinga, I., Kuhlmann, T., Lucchinetti, C. F., Metz, I., Reynolds, R., et al. (2022) · Brain Communications · doi:10.1093/braincomms/fcac094 · Cited by 13
Self-citation
Myelin Oligodendrocyte Glycoprotein as an Autoantigen in Inflammatory Demyelinating Diseases of the Central Nervous System
Eliseeva, D. D., & Zakharova, M. N. (2023) · Biochemistry (Moscow) · doi:10.1134/s0006297923040107 · Cited by 12
Proteomics and relationship with axonal pathology in multiple sclerosis: 5-year diffusion tensor imaging study
Jakimovski, D., Qureshi, F., Ramanathan, M. K., Gehman, V. M., Keshavan, A., Leyden, K. M., Dwyer, M. G., Bergsland, N., Weinstock‐Guttman, B., & Zivadinov, R. (2023) · Brain Communications · doi:10.1093/braincomms/fcad183 · Cited by 12
New views on the complex interplay between degeneration and autoimmunity in multiple sclerosis
Stys, P. K., Tsutsui, S., Gafson, A., Hart, B. A. ‘., Belachew, S. M., & Geurts, J. J. G. (2024) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2024.1426231 · Cited by 14
Spatial mapping of the AA-PGE2-EP axis in multiple sclerosis lesions
Hansen, C. E., Konings, J., Tóth, G. J., Chornyi, S., Karsten, M., Hof, B. V. H., van der Pol, S. M. A., Beekhuis-Hoekstra, S. D., Kok, N., Fung, W. K., et al. (2025) · Acta Neuropathologica · doi:10.1007/s00401-025-02878-3 · Cited by 12
New Ways of “Seeing” the Mechanistic Heterogeneity of Multiple Sclerosis Plaque Pathogenesis
Meltzer, E. I., Costello, F., Frohman, E. M., & Frohman, T. C. (2018) · Journal of Neuro-Ophthalmology · doi:10.1097/wno.0000000000000633 · Cited by 12
Acute vestibular syndrome and hearing loss mimicking labyrinthitis as initial presentation of multiple sclerosis
Valente, P., Pinto, I., Aguiar, C., Castro, E., Conde, A., & Larangeiro, J. (2020) · International Journal of Pediatric Otorhinolaryngology · doi:10.1016/j.ijporl.2020.110048 · Cited by 12
Viscoelastic properties of white and gray matter-derived microglia differentiate upon treatment with lipopolysaccharide but not upon treatment with myelin
van Wageningen, T. A., Antonovaité, N., Paardekam, E. J., Brevé, J. J. P., Iannuzzi, D., & van Dam, A. (2021) · Journal of Neuroinflammation · doi:10.1186/s12974-021-02134-x · Cited by 12
Bruton’s tyrosine kinase as a promising therapeutic target for multiple sclerosis
Saberi, D., Geladaris, A., Dybowski, S., & Weber, M. S. (2023) · Expert Opinion on Therapeutic Targets · doi:10.1080/14728222.2023.2218615 · Cited by 12
Carnosine synthase deficiency aggravates neuroinflammation in multiple sclerosis
Spaas, J., der Stede, T. V., de Jager, S., Berends, A. V. D. W., Tiane, A., Baelde, H. J., Baba, S. P., Eckhardt, M., Wolfs, E., Vanmierlo, T., et al. (2023) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2023.102532 · Cited by 12
p38γ MAPK delays myelination and remyelination and is abundant in multiple sclerosis lesions
Marziali, L. N., Hwang, Y., Palmisano, M., Cuenda, A., Sim, F. J., Gonzalez, A., Volsko, C. M., Dutta, R., Trapp, B. D., Wrabetz, L. G., et al. (2023) · Brain · doi:10.1093/brain/awad421 · Cited by 13
Comparison of histological procedures and antigenicity of human post-mortem brains fixed with solutions used in gross anatomy laboratories
Frigon, É., Gérin‐Lajoie, A., Dadar, M., Boire, D., & Maranzano, J. (2024) · Frontiers in Neuroanatomy · doi:10.3389/fnana.2024.1372953 · Cited by 12
Intrinsic and extrinsic contributors to subregional thalamic volume loss in multiple sclerosis
Krijnen, E. A., Karam, E. S., Russo, A. W., Lee, H., Chiang, F. L., Schoonheim, M. M., Huang, S. Y., & Klawiter, E. C. (2024) · Annals of Clinical and Translational Neurology · doi:10.1002/acn3.52026 · Cited by 12
Seasonal Variations in Macrophages/Microglia Underlie Changes in the Mouse Model of Multiple Sclerosis Severity
Álvarez‐Sánchez, N., Cruz‐Chamorro, I., Álvarez‐López, A. I., González, A. L., Lacalle-Remigio, J. R., Lardone, P. J., Guerrero, J. M., Martínez‐López, A., & Carrillo‐Vico, A. (2020) · Molecular Neurobiology · doi:10.1007/s12035-020-02017-x · Cited by 12
Antigenicity is preserved with fixative solutions used in human gross anatomy: A mice brain immunohistochemistry study
Frigon, É., Dadar, M., Boire, D., & Maranzano, J. (2022) · Frontiers in Neuroanatomy · doi:10.3389/fnana.2022.957358 · Cited by 13
Association of retinal vessel pathology and brain atrophy in relapsing-remitting multiple sclerosis
Romahn, E. F., Wiltgen, T., Bussas, M., Aly, L., Wicklein, R., Noll, C., Berthele, A., Dehmelt, V., Mardin, C. Y., Zimmer, C., et al. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1284986 · Cited by 14
Uncovering Novel Extracellular Matrix Transcriptome Alterations in Lesions of Multiple Sclerosis
Stephenson, E. L., Jain, R. W., Ghorbani, S., Gorter, R. P., D’Mello, C., & Yong, V. W. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25021240 · Cited by 11
Microglia and Multiple Sclerosis
Hammond, B. P., Panda, S. P., Kaushik, D. K., & Plemel, J. R. (2024) · Advances in neurobiology · doi:10.1007/978-3-031-55529-9_25 · Cited by 11
Should We Consider Neurodegeneration by Itself or in a Triangulation with Neuroinflammation and Demyelination? The Example of Multiple Sclerosis and Beyond
Perdaens, O., & Pesch, V. V. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms252312637 · Cited by 12
MOG35 − 55-induced EAE model of optic nerve inflammation compared to MS, MOGAD and NMOSD related subtypes of human optic neuritis
Capper, E. N., Linton, E. F., Anders, J. J., Kardon, R. H., & Gramlich, O. W. (2025) · Journal of Neuroinflammation · doi:10.1186/s12974-025-03424-4 · Cited by 11
The regulation of microglia by aging and autophagy in multiple sclerosis
Wang, X., Sun, Y., Yu, H., Xue, C., Pei, X., Chen, Y., & Guan, Y. (2025) · Pharmacological Research · doi:10.1016/j.phrs.2025.107786 · Cited by 11
Multiple sclerosis: etiology in the context of neurovascular unit and immune system involvement and advancements with in vitro blood–brain barrier models
El-Taibany, A. A., Heydarian, P., Porada, D. A., Seeds, M. C., & Atala, A. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1595276 · Cited by 11
Unbiased examination of genome-wide human endogenous retrovirus transcripts in MS brain lesions
Elkjaer, M. L., Frisch, T., Tonazzolli, A., Röttger, R., Reynolds, R., Baumbach, J., & Illés, Z. (2021) · Multiple Sclerosis Journal · doi:10.1177/1352458520987269 · Cited by 11
Mechanisms of Neurodegeneration in Multiple Sclerosis
Eliseeva, D. D., & Zakharova, M. N. (2022) · S S Korsakov Journal of Neurology and Psychiatry · doi:10.17116/jnevro20221220725 · Cited by 11
In vivo characterization of microglia and myelin relation in multiple sclerosis by combined 11C-PBR28 PET and synthetic MRI
Barletta, V. T., Herranz, E., Treaba, C. A., Mehndiratta, A., Ouellette, R., Granberg, T., Klawiter, E. C., Ionete, C., Sloane, J. A., & Mainero, C. (2023) · Journal of Neurology · doi:10.1007/s00415-023-11621-5 · Cited by 11
Epstein-Barr Virus and Multiple Sclerosis: A Convoluted Interaction and the Opportunity to Unravel Predictive Biomarkers
Ortega‐Hernandez, O., Martínez-Cáceres, E. M., Presas‐Rodríguez, S., & Ramo-Tello, C. M. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24087407 · Cited by 12
Molecular mimicry between Zika virus and central nervous system inflammatory demyelinating disorders: the role of NS5 Zika virus epitope and PLP autoantigens
França, L. C., Fontes-Dantas, F. L., Garcia, D. G., de Araújo, A. D., Gonçalves, J. P. D. C., Rêgo, C. C. D. S., da Silva, E. V., Nascimento, O. J. M., Lopes, F. C. R., Herlinger, A. L., et al. (2023) · Arquivos de Neuro-Psiquiatria · doi:10.1055/s-0043-1768698 · Cited by 11
Age-related changes in multiple sclerosis and experimental autoimmune encephalomyelitis
Zuo, M., Ramaglia, V., & Gommerman, J. L. (2022) · Seminars in Immunology · doi:10.1016/j.smim.2022.101631 · Cited by 11
Machine learning for refining interpretation of magnetic resonance imaging scans in the management of multiple sclerosis: a narrative review
Szekely-Kohn, A. C., Castellani, M., Espino, D. M., Baronti, L., Ahmed, Z., Manifold, W. G. K., & Douglas, M. (2025) · Royal Society Open Science · doi:10.1098/rsos.241052 · Cited by 12
Impaired remyelination in late-onset multiple sclerosis
Stork, L., Stephan, S., Kutllovci, A., Brück, W., & Metz, I. (2025) · Acta Neuropathologica · doi:10.1007/s00401-025-02868-5 · Cited by 10
Self-citation
The Heterogeneous Multiple Sclerosis Lesion: How Can We Assess and Modify a Degenerating Lesion?
Ellen, O., Ye, S., Nheu, D., Dass, M., Pagnin, M., Öztürk, E., Theotokis, P., Grigoriadis, N., & Petratos, S. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241311112 · Cited by 11
The role of biogenic amines in the modulation of monocytes in autoimmune neuroinflammation
Belousova, O., Lopatina, A., Kuzmina, U. S., & Melnikov, M. (2023) · Multiple Sclerosis and Related Disorders · doi:10.1016/j.msard.2023.104920 · Cited by 10
Autofluorescence spectroscopy as a proxy for chronic white matter pathology
Morgan, M. L., Kaushik, D. K., Stys, P. K., & Caprariello, A. V. (2020) · Multiple Sclerosis Journal · doi:10.1177/1352458520948221 · Cited by 10
Foamy microglia link oxylipins to disease progression in multiple sclerosis
van der Vliet, D., Di, X., Shamorkina, T. M., Coulon-Bainier, C., Pavlovic, A., van der Vliet, I. A. C. M., Zeng, Y., Macnair, W., van Egmond, N., Chen, J. Q. A., et al. (2026) · Nature Neuroscience · doi:10.1038/s41593-026-02302-3 · Cited by 9
Inflammatory microglia correlate with impaired oligodendrocyte maturation in multiple sclerosis
Chen, J. Q. A., Wever, D. D., McNamara, N. B., Bourik, M., Smolders, J., Hamann, J., & Huitinga, I. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1522381 · Cited by 9
Inflammation’s impact on the interaction between oligodendrocytes and axons
Green, T. R. F., Pingen, M., & Edgar, J. M. (2025) · Discovery Immunology · doi:10.1093/discim/kyaf008 · Cited by 11
Multiple sclerosis: a practical review for pathologists
Multz, R. A., Jamshidi, P., & Ahrendsen, J. T. (2025) · Journal of Pathology and Translational Medicine · doi:10.4132/jptm.2025.05.20 · Cited by 12
Using quantitative magnetic resonance imaging to track cerebral alterations in multiple sclerosis brain: A longitudinal study
Vandeleene, N., Guillemin, C., Dauby, S., Requier, F., Charonitis, M., Chylinski, D., Balteau, E., Maquet, P., Lommers, É., & Phillips, C. L. M. (2023) · Brain and Behavior · doi:10.1002/brb3.2923 · Cited by 10
Profiling migration of human monocytes in response to chemotactic and barotactic guidance cues
Hall, C. K., Barr, O. M., Delamare, A., Burkholder, A., Tsai, A., Tian, Y., Ellett, F. E., Li, B. M., Tanzi, R. E., & Jorfi, M. (2024) · Cell Reports Methods · doi:10.1016/j.crmeth.2024.100846 · Cited by 10
Phenotyping in vivo chronic inflammation in multiple sclerosis by combined 11 C-PBR28 MR-PET and 7T susceptibility-weighted imaging
Treaba, C. A., Herranz, E., Barletta, V. T., Mehndiratta, A., Sloane, J. A., Granberg, T., Miscioscia, A., Bomprezzi, R., Loggia, M. L., & Mainero, C. (2024) · Multiple Sclerosis Journal · doi:10.1177/13524585241284157 · Cited by 9
Cortical and meningeal pathology in progressive multiple sclerosis: a new therapeutic target?
Silva, B. A., & Ferrari, C. C. (2018) · Reviews in the Neurosciences · doi:10.1515/revneuro-2018-0017 · Cited by 10
A Case of Multiple Sclerosis—Like Relapsing Remitting Encephalomyelitis Following Allogeneic Hematopoietic Stem Cell Transplantation and a Review of the Published Literature
Das, J., Gill, A. M., Lo, C., Chan-Lam, N., Price, S., Wharton, S. B., JESSOP, H. L., Sharrack, B., & Snowden, J. A. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.00668 · Cited by 9
In Vivo Proton Exchange Rate (kex) MRI for the Characterization of Multiple Sclerosis Lesions in Patients
Ye, H., Shaghaghi, M., Chen, Q., Zhang, Y., Lutz, S. E., Chen, W., & Cai, K. (2020) · Journal of Magnetic Resonance Imaging · doi:10.1002/jmri.27363 · Cited by 9
From Baló’s concentric sclerosis to multiple sclerosis: a series of 6 patients
Ayrignac, X., Guillon, L. L., Dalliere, C. C., Duquette, P., Girard, M., Poirier, J. B., Lahav, B., Larochelle, C., & Prat, A. (2020) · Multiple Sclerosis and Related Disorders · doi:10.1016/j.msard.2020.102078 · Cited by 9
Self-citation
Textural analysis and artificial intelligence as decision support tools in the diagnosis of multiple sclerosis – a systematic review
Orzan, F., Iancu, Ș. D., Dioşan, L. S., & Bálint, Z. (2025) · Frontiers in Neuroscience · doi:10.3389/fnins.2024.1457420 · Cited by 9
The Dual Role of Microglia in Multiple Sclerosis and its Implications for Diagnostics and Repair
Goulart, M. T., Queiroz, D. T. U., & Ribeiro, F. M. (2025) · Current Neuropharmacology · doi:10.2174/011570159x352356241126044933 · Cited by 8
Diffusivity anisotropy signature of slowly expanding lesions predicts progression independent of relapse activity in multiple sclerosis
Calvi, A., Vivó, F., Solana, E., López-Soley, E., Kanber, B., Albà-Arbalat, S., Sepúlveda, M., Martínez‐Hernández, E., Cabrera‐Maqueda, J. M., Fonseca, E. G., et al. (2025) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp-2025-335884 · Cited by 9
Cell death in multiple sclerosis
Guan, S., Zhu, H., Zhang, M., Shi, F., & Yan, B. (2025) · Cell Death and Differentiation · doi:10.1038/s41418-025-01576-7 · Cited by 8
Age-impaired remyelination is associated with dysregulated microglial transitions
Zia, S., Traetta, M. E., Baaklini, C. S., Hammond, B. P., John, R. K., Souter, K. M., Meijns, N., Afun, L. K. A., Panda, S. P., Ibáñez, F. G., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-64906-w · Cited by 10
Oxidized phosphatidylcholines deposition drives chronic neurodegeneration in a mouse model of progressive multiple sclerosis via IL-1β signaling
Yu, R., Lozinski, B. M., Seifert, A., Ta, K., Zandee, S., Kaushik, D. K., Park, J., Klément, W., Larouche, S., Tsimikas, S., et al. (2025) · Nature Neuroscience · doi:10.1038/s41593-025-02113-y · Cited by 10
Self-citation
Transcriptomic changes in autophagy-related genes are inversely correlated with inflammation and are associated with multiple sclerosis lesion pathology
Misrielal, C., Alsema, A. M., Wijering, M. H. C., Miedema, A., Mauthe, M., Reggiori, F., & Eggen, B. J. L. (2022) · Brain Behavior & Immunity - Health · doi:10.1016/j.bbih.2022.100510 · Cited by 9
Clostridium perfringens Epsilon Toxin Binds to and Kills Primary Human Lymphocytes
Shetty, S. V., Mazzucco, M. R., Winokur, P. N., Haigh, S. V., Rumah, K. R., Fischetti, V. A., Vartanian, T. K., & Linden, J. R. (2023) · Toxins · doi:10.3390/toxins15070423 · Cited by 8
Practical considerations for birefringence microscopy of myelin structure: Microscope design and tissue processing for effective imaging
Blanke, N., Gray, A. J., Robinson, R. E., Novoseltseva, A., Rosene, D. L., & Bigio, I. J. (2024) · Imaging Neuroscience · doi:10.1162/imag_a_00186 · Cited by 8

Authors: Kuhlmann, T., Ludwin, S., Prat, A., Antel, J., Brück, W., & Lassmann, H.
Affiliations: University Hospital Münster (DE)
Montreal Neurological Institute and Hospital (CA)
Centre Hospitalier de l’Université de Montréal (CA)
Universitätsmedizin Göttingen (DE)
Medical University of Vienna (AT)
Corresponding author: Kuhlmann, Tanja
ORCID: Kuhlmann, Tanja
Prat, Alexandre
Antel, Jack
Brück, Wolfgang
Lassmann, Hans
Venue: Acta Neuropathologica
Publisher: Springer Science and Business Media LLC
Published: 2016-12-17
Volume: 133
Issue: 1
Pages: 13-24
ISSN: 0001-6322 (ISSN-L)
1432-0533
DOI: 10.1007/s00401-016-1653-y
OpenAlex: W2562977489
Cited by: 692
References: 59
Citations by year: 2026: 58 · 2025: 87 · 2024: 113 · 2023: 81 · 2022: 99 · 2021: 83 · 2020: 59 · 2019: 51 · 2018: 42 · 2017: 17
FWCI: 33.28
Type: journal article
Language: en
Open access: closed
Licence: www.springer.com/tdm (unspecified)
Locations: Acta Neuropathologica (publishedVersion)
PubMed (publishedVersion)
GRO (submittedVersion)
Funders: Deutsche Forschungsgemeinschaft (SFB-TRR128 B-7, Ku1477/6-1)
IZKF (KuT3/012/15)
Austrian Science Fund (FWF Project I 2114-B27)
CIHR; Quebec, FRQS
CIHR, Quebec, FRQS
BMBF, KKNMS
Topics: Health Sciences › Medicine › Clinical Neurology › Multiple Sclerosis Research Studies
Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
Health Sciences › Medicine › Clinical Neurology › Peripheral Neuropathies and Disorders
Keywords: multiple sclerosis, histological classification, demyelination, macrophages, microglia, active lesions, myelin basic protein, proteolipid protein, myelin oligodendrocyte glycoprotein, myelin-associated glycoprotein, cortical pathology, remyelination, demyelinating disease, central nervous system lesions, neuropathology
MeSH terms: Animals, Humans, Macrophages, Multiple Sclerosis, Microglia, White Matter

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

An updated histological classification system for multiple sclerosis lesions

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks